Genomics of Drug Sensitivity in Cancer |
PFI-1
|
Synonyms |
|
Targets |
BRD4
|
Target pathway |
Chromatin other
|
PubCHEM ID |
71271629
|
Jsmol |
|
Download molecule |
71271629
|
PUBCHEM IUPAC INCHI |
InChI=1S/C16H17N3O4S/c1-19-10-11-9-12(7-8-13(11)17-16(19)20)18-24(21,22)15-6-4-3-5-14(15)23-2/h3-9,18H,10H2,1-2H3,(H,17,20)
|
Smiles |
S(=O)(=O)(NC2(=CC1(=C(NC(=O)N(C1)C)C=C2)))C3(=C(OC)C=CC=C3)
|
Cluster number |
16
|
calculated LogS |
-3,363
|
Molecular weight |
347,394
|
calculated LogP |
0,8236
|
H-Acceptors |
7
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
1,3232
|
DrugScore |
0,455666580491256
|
Mutagenic |
high
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,6147
|
Rat Acute Toxicity |
2,2248
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
0,8917
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,4491
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Lysosome
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,4969
|